Australia Medical Marijuana Market Size & Outlook
Australia medical marijuana market, 2018-2030 (US$M)
Related Markets
Australia medical marijuana market highlights
- The Australia medical marijuana market generated a revenue of USD 21.6 million in 2023 and is expected to reach USD 142.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 31% from 2024 to 2030.
- In terms of segment, oil and tinctures was the largest revenue generating product in 2023.
- Oil and Tinctures is the most lucrative product segment registering the fastest growth during the forecast period.
Medical marijuana market data book summary
| Market revenue in 2023 | USD 21.6 million |
| Market revenue in 2030 | USD 142.8 million |
| Growth rate | 31% (CAGR from 2023 to 2030) |
| Largest segment | Oil and tinctures |
| Fastest growing segment | Oil and Tinctures |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Flower, Oil and Tinctures |
| Key market players worldwide | Tilray Brands Inc, Aurora Cannabis Inc, Canopy Growth Corp, Aphria Inc, Wayland Group Corp, Aurora Cannabis, GW Pharmaceuticals, Cannabis Sativa Inc, Medical Marijuana Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 0.1% of the global medical marijuana market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Thailand medical marijuana market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,435.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Marijuana Market Scope
Medical Marijuana Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia medical marijuana market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical marijuana market will help companies and investors design strategic landscapes.
Oil and tinctures was the largest segment with a revenue share of 53.24% in 2023. Horizon Databook has segmented the Australia medical marijuana market based on flower, oil and tinctures covering the revenue growth of each sub-segment from 2018 to 2030.
- Australia Medical Marijuana Product Outlook (Revenue, USD Million, 2018-2030)
- Flower
- Oil and Tinctures
- Australia Medical Marijuana Application Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Diabetes
- Glaucoma
- Migraines
- Epilepsy
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Alzheimers's
- Post Traumatic Stress Disorder (PTSD)
- Parkinson's
- Tourettes
- Others
Reasons to subscribe to Australia medical marijuana market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia medical marijuana market databook
-
Our clientele includes a mix of medical marijuana market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia medical marijuana market , including forecasts for subscribers. This country databook contains high-level insights into Australia medical marijuana market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia medical marijuana market size, by product, 2018-2030 (US$M)
Australia Medical Marijuana Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
